Thursday, September 15, 2011 9:23:07 PM
Don't just take my word for it.Read the financials.Such as this one filed after 9 months of share selling.
http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001477932%2D11%2D000853%2Etxt&FilePath=%5C2011%5C06%5C06%5C&CoName=INOLIFE+TECHNOLOGIES%2C+INC%2E&FormType=8%2DK&RcvdDate=6%2F6%2F2011&pdf=
""The items in the Forms 10-Q/A (Amendment No.1) for the quarters ending September 30, 2010 and December 31, 2010 which are being amended and restated as a result of the foregoing are:
? Part I; Item 1. Financial Statements, including Consolidated Balance Sheets Consolidated Statement of Operations, Consolidated Statement of Stockholders’ Equity, Consolidated Statements of Cash Flows and Notes to Unaudited Consolidated Financial Statements;
? Part I; Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations; and
? Part II, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
The Company’s Chief Executive Officer has discussed these matters with EFP Rotenberg, LLP, the Company’s independent registered public accounting firm, who concurs with the need for restatements.
Until we have reissued the restated results for the applicable periods discussed above, investors and other users of our filings with the SEC are cautioned not to rely on our financial statements in question, to the extent that they are affected by the accounting issues described above.
Copies of the Consulting Agreements are filed as exhibits to this Current Report on Form 8-K. All disclosures set forth in this Current Report on Form 8-K are qualified by and subject to the Consulting Agreements.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit 10.1 Continental Investment Group, Inc. Consulting Agreement
Exhibit 10.2 TRO Investments, Inc. Consulting Agreement
Exhibit 10.3 Connied, Inc. Consulting Agreement
Exhibit 10.4 Fuselier and Co, Inc. Consulting Agreement ""
The rest of them are here.
http://www.nasdaq.com/asp/quotes_sec.asp?symbol=INOL&selected=INOL
Gonna make a difference !
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM